Claim Missing Document
Check
Articles

Found 3 Documents
Search

The Effectiveness of Multimodal Treatment Strategies (Antibiotics, Anti-inflammatory Drugs, and Lifestyle Modifications) in Reducing Prostatitis Symptoms: A Systematic Review Ilham Saptia Nugraha; John M. Sangkai
The International Journal of Medical Science and Health Research Vol. 15 No. 4 (2025): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/20y83c13

Abstract

Introduction: Prostatitis, particularly Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS), is a prevalent and debilitating condition with a profound negative impact on patients' quality of life. Its complex, multifactorial pathophysiology, involving infection, inflammation, and neuromuscular dysfunction, renders traditional monotherapy largely ineffective. This systematic review synthesizes the evidence on the effectiveness of multimodal treatment strategies to establish an evidence-based standard of care. Methods: Following PRISMA guidelines, a systematic search of PubMed, Semantic Scholar, Springer, Google Scholar, and Wiley Online Library was conducted. The review included randomized controlled trials and prospective cohort studies evaluating multimodal therapies (combinations of antibiotics, anti-inflammatories, and/or lifestyle modifications) in adult men with prostatitis. The primary outcome was the mean change in the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) score. Results: The analysis of six selected studies demonstrated that multimodal therapies lead to statistically and clinically significant reductions in prostatitis symptoms. Pharmacological combinations of alpha-blockers, anti-inflammatories, and antibiotics resulted in substantial decreases in NIH-CPSI scores. The integration of structured lifestyle modifications, such as diet and aerobic exercise, further enhanced symptom control. Phenotype-directed therapy using the UPOINT system, which tailors treatment to individual symptom domains, proved most effective, with over 75% of patients achieving a clinically significant response. Discussion: The superiority of a multimodal approach stems from its synergistic ability to simultaneously target the distinct pathophysiological domains of prostatitis. The UPOINT framework signifies a paradigm shift towards personalized medicine, enabling clinicians to move beyond a "one-size-fits-all" strategy to a tailored, effective treatment plan. These findings strongly align with and provide a quantitative evidence base for current AUA and EAU clinical practice guidelines that advocate for multimodal management. Conclusion: This review consolidates robust evidence that multimodal treatment, particularly when guided by clinical phenotyping like the UPOINT system, is unequivocally superior to monotherapy. It represents the gold-standard, evidence-based paradigm for managing prostatitis, offering patients the greatest potential for meaningful symptom improvement.
How does Testosterone Therapy Impact Quality of Life and Cancer Recurrence Rates in High-Risk Prostate Cancer Survivors? : A Systematic Review Salman Alfarisi Kuddah; John M. Sangkai
The International Journal of Medical Science and Health Research Vol. 16 No. 2 (2025): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/j0xqbk37

Abstract

Introduction: The use of testosterone therapy (TRT) to manage hypogonadal symptoms in prostate cancer survivors is clinically contentious due to long-standing fears that it may promote cancer recurrence. Definitive treatments often lead to debilitating side effects like fatigue and loss of libido, creating a dilemma between improving quality of life (QoL) and ensuring oncological safety. This systematic review evaluates the impact of testosterone therapy on biochemical recurrence rates and QoL in high-risk prostate cancer survivors. Methods: Following PRISMA 2020 guidelines, a systematic search was conducted across PubMed, Springer, Google Scholar, and Semantic Scholar for studies published since 2015. Eligibility criteria targeted randomized controlled trials and prospective cohort studies assessing TRT in adult males after primary treatment for high-risk prostate cancer, with outcomes of cancer recurrence and/or QoL. After screening 763 records, 19 studies were included in the final analysis. Results: The synthesized evidence did not show a significant increase in biochemical recurrence with TRT. Several studies reported low recurrence rates, with one frequency-matched study finding that TRT was associated with a 1.4-year delay in recurrence. Conversely, a critical deficiency in QoL data was identified; 16 of the 19 included studies did not use validated assessment tools to measure patient-reported outcomes. Reported adverse events were generally low-grade and manageable. Conclusion: A notable discordance exists between the emerging oncological safety of TRT and the profound lack of evidence supporting its benefits for QoL in high-risk prostate cancer survivors. While the historical fear of cancer recurrence is not strongly supported by recent data, the therapy's actual benefit to patients remains largely unquantified. Future research must prioritize QoL as a primary endpoint to establish a definitive risk-benefit profile.
Non-Sterile Clean Gloves versus Sterile Gloves for Uncomplicated Wound and Laceration Repair: A Systematic Review of Clinical, Economic, and Patient-Reported Outcomes Regenio Akira Handoyo; John M. Sangkai
The Indonesian Journal of General Medicine Vol. 18 No. 1 (2025): The Indonesian Journal of General Medicine
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/y0krv256

Abstract

Introduction The use of sterile gloves is a deeply entrenched standard of care for surgical procedures, including the repair of cutaneous wounds and lacerations, to prevent surgical site infections (SSIs). However, this practice is resource-intensive and its necessity for minor, non-operating room procedures is increasingly questioned. This review evaluates the clinical and economic rationale for using clean, non-sterile gloves as an evidence-based alternative in outpatient and emergency settings (Hamam et al., 2024; Brewer et al., 2016). Methods A systematic review and meta-analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Major electronic databases (PubMed, Embase, Cochrane CENTRAL, and CINAHL) were searched through May 2024 for randomized controlled trials (RCTs) and comparative observational studies comparing sterile versus non-sterile gloves for wound repair (Hamam et al., 2024). The primary outcome was the incidence of SSI. Secondary outcomes (16 total) included cost-effectiveness, procedure duration, and adverse events. Methodological quality was rigorously assessed using the Cochrane Risk of Bias 2 (RoB 2) and Risk of Bias in Non-randomised Studies - of Interventions (ROBINS-I) tools (Mahraoui et al., 2024; Hamam et al., 2024). Results Ten primary studies (6 RCTs, 4 observational) and three systematic reviews, encompassing over 21,000 patients, met the inclusion criteria. The quantitative meta-analysis of RCTs found no statistically significant difference in the incidence of SSI between the non-sterile glove group and the sterile glove group. Pooled data from recent meta-analyses confirm this finding (Risk Ratio 1.17, 95% Confidence Interval [CI] 0.88–1.55, P=.62) (Hamam et al., 2024). This result was highly robust, with no statistical heterogeneity (I² = 0%) (Hamam et al., 2024; Brewer et al., 2016). Evidence from multiple primary studies confirmed that non-sterile gloves are a highly cost-effective option, with sterile gloves costing up to seven times more per pair (Perelman et al., 2004; Mehta et al., 2014). Discussion The aggregated evidence demonstrates high-confidence non-inferiority for the use of clean, non-sterile gloves in uncomplicated, superficial wound repairs in immunocompetent patients (Heal et al., 2015; Zwaans et al., 2022). This is clinically plausible as traumatic lacerations are already contaminated, and a "clean" technique (including sterile instruments) is sufficient to prevent iatrogenic infection. However, the evidence clearly does not support non-sterile glove use for high-risk scenarios, such as in immunocompromised patients (Zwaans et al., 2022) or for complex, deep-tissue reconstructions (Rogues et al., 2007). A significant gap exists in the literature regarding patient-reported outcomes, particularly long-term cosmetic results. Conclusion Clean, non-sterile gloves are a safe, cost-effective, and evidence-based standard of care for the vast majority of uncomplicated laceration and wound repairs performed outside a formal operating room in immunocompetent patients. Clinical guidelines and institutional policies should be updated to reflect this evidence, promoting high-value care and reducing medical waste.